Example: marketing
New Zealand Data Sheet - Medsafe
As with other topical corticosteroids, when extensive areas are treated, sufficient systemic absorption may occur to produce the features of hypercorticalism.
Information
Domain:
Source:
Link to this page:
Documents from same domain
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
Related documents
Specialists In Reproductive Medicine & Surgery, P.A.
www.dreamababy.comPatient Information Summary, Oocyte Cryopreservation (cont.) Page 2 of 6 Destructive pelvic disease: Prior to pelvic surgery for benign disease if the surgery may place her at risk for reduced fertility. Prior to medical treatment: Prior to medical treatment that my impair fertility. Do not want excess
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) …
www.derbyshiremedicinesmanagement.nhs.ukFor agenda items contact Slakahan Dhadli Tel: 01332 868781 Email: slakahan.dhadli@southernderbyshireccg.nhs.ukk 5 Item Action and transferred over when there was a reasonable likelihood that they would be
What is the most important information I should know about ...
www.janssenlabels.comMEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets What is the most important information I should know about XARELTO? • For people taking XARELTO for atrial fibrillation: People with atrial fibrillation (an irregular heart beat) are at an increased risk of …
NEW ZEALAND DATA SHEET EFUDIX® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET EFUDIX® 2 Limitation of Treatment Area The total area of skin being treated with EFUDIX cream at any time should not exceed 500 square
for those who are bringing medicines into Japan
www.mhlw.go.jp4) Document indicating Arrival Date and Place ( ex. Copy of Airline Ticket or Flight Itinerary. ) 5) (If you need an original “Yakkan Shoumei”) Return Envelope with Japanese Postal Stamps required and with Address where you want to receive a “Yakkan Shoumei”.